Meprobamate
NDC 62332-019, Meprobamate, tablet, from Alembic Pharmaceuticals Inc..
- Product NDC
- 62332-019
- Status
- Listed
- Labeler
- Alembic Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090122
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/62332-019 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEPROBAMATE200 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62332-019-30 | 62332001930 | 30 TABLET in 1 BOTTLE (62332-019-30) |
| 62332-019-31 | 62332001931 | 100 TABLET in 1 BOTTLE (62332-019-31) |
| 62332-019-91 | 62332001991 | 1000 TABLET in 1 BOTTLE (62332-019-91) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3b255bcd-0218-44f8-830b-971f5ec45276NADAC price for package 62332001931
GET /v1/drugs/nadac/62332001931
Use it
Look up 62332-019 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62332-019 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62332-019. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.